Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)
China · Delayed Price · Currency is CNY 6.61
-0.05 (-0.75%)
Sep 10, 2026, 2:10 PM CST
SHE:002550 Revenue
Changzhou Qianhong Biopharma CO.,LTD had revenue of 400.29M CNY in the quarter ending June 30, 2026, a decrease of -2.58%. This brings the company's revenue in the last twelve months to 1.47B, down -4.21% year-over-year. In the year 2025, Changzhou Qianhong Biopharma CO.,LTD had annual revenue of 1.57B with 2.95% growth.
Revenue (ttm)
1.47B
Revenue Growth
-4.21%
P/S Ratio
5.67
Revenue / Employee
1.41M
Employees
1,038
Market Cap
8.32B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.57B | 45.03M | 2.95% |
| Dec 31, 2024 | 1.53B | -288.03M | -15.88% |
| Dec 31, 2023 | 1.81B | -489.28M | -21.24% |
| Jan 1, 2023 | 2.30B | 428.61M | 22.86% |
| Jan 1, 2022 | 1.87B | 207.33M | 12.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| North China Pharmaceutical Company.Ltd | 8.19B |
| Shandong Lukang Pharmaceutical | 5.85B |
| Zhejiang Xianju Pharmaceutical | 3.85B |
| Beijing Foyou Pharma CO.,LTD | 3.58B |
| Tianjin Ringpu Bio-Technology | 3.41B |
| Jiuzhitang | 2.60B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 2.04B |
| Zhejiang Hisoar Pharmaceutical | 1.96B |